Similar articles

• [Malignant melanoma and L-dopa. Review of literature on the problem of causal relationship].

  Happle. Happle. Fortschr Med. 1974 Sep 26;92(27):1065-6. Fortschr Med. 1974. PMID: 4457419 German. No abstract available.
• Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.

  Pfützner W, Przybilla B. Pfützner W, et al. J Am Acad Dermatol. 1997 Aug;37(2 Pt 2):332-6. J Am Acad Dermatol. 1997. PMID: 9270541 Review.
• Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.

  Zanetti R, Loria D, Rosso S. Zanetti R, et al. Melanoma Res. 2006 Jun;16(3):201-6. doi: 10.1097/01.cmr.0000215043.61306.d7. Melanoma Res. 2006. PMID: 16718266 Review.
• Parkinson's disease, levodopa-use and the risk of melanoma.

  Vermeij JD, Winogrodzka A, Trip J, Weber WE. Vermeij JD, et al. Parkinsonism Relat Disord. 2009 Sep;15(8):551-3. doi: 10.1016/j.parkreldis.2009.05.002. Epub 2009 Jun 5. Parkinsonism Relat Disord. 2009. PMID: 19501540 Review.
• [Letter: Malignant melanoma during treatment with levodopa].

  Pelfréne AF. Pelfréne AF. Nouv Presse Med. 1975 May 3;4(18):1365. Nouv Presse Med. 1975. PMID: 1153302 French. No abstract available.